Anti-CDH17 antibodies and their uses
CL202600836A1Pending Publication Date: 2026-08-28LEPU BIOPHARMA CO LTD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CL202600836
- Authority / Receiving Office
- CL · CL
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-09-20
- Filing Date
- 2026-03-20
- Publication Date
- 2026-08-28
Abstract
Antibodies with high selective specificity for the human CDH17 protein have been identified and are useful for cancer treatment. These antibodies can be used to prepare antibody-drug conjugates, which demonstrate effective cell destruction in vitro and in vivo.
Need to check novelty before this filing date? Find Prior Art